Gabriel Mannis, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Gabriel Mannis, MD

Assistant Professor, Hematology/Blood and Marrow Transplantation, UCSF

Gabriel.Mannis@ucsf.edu

Phone: (415) 353-2421
Box 0324, UCSF
San Francisco, CA 94143

UCSF Profiles

Cancer Center Membership

Associate Member » Hematopoietic Malignancies

Education

Harvard University, B.A., 07/96 - 06/00, Romance Languages and Literature
University of California, Davis School of Medicine, M.D., 07/03 - 6/08, Medicine
UCSF Medical Center, 07/08 - 06/11, Internship/Residency, Internal Medicine
UCSF Medical Center, 07/11 - 06/14 Fellowship, Hematology/Oncology

Honors & Awards

  • 2000
    Harvard College Scholarship, Harvard University, Cambridge, MA
  • 2005
    Howard Hughes Medical Institute (HHMI) – National Institutes of Health (NIH) Research Scholar, Bethesda, MD
  • 2007
    Alpha Omega Alpha, University of California, Davis School of Medicine, Sacramento, CA
  • 2007
    Major C.W. Offutt VA Medical Center Award, University of California, Davis School of Medicine, Sacramento, CA
  • 2008
    Ernest M. Gold Award for Excellence in Internal Medicine, University of California, Davis School of Medicine, Sacramento, CA
  • 2011
    UCSF Internal Medicine Residency Professionalism Award, University of California, San Francisco Medical Center, San Francisco, CA
  • 2011
    Teaching Excellence Award for Cherished Housestaff, University of California, San Francisco Medical Center, San Francisco, CA
  • 2012
    Clinical Fellow Award, Hematology/Oncology Division, University of California, San Francisco Medical Center, San Francisco, CA
  • 2013
    Edward S. Ageno Family Endowed Fellowship in Hematology, University of California, San Francisco Medical Center, San Francisco, CA
  • 2013
    Clinical Fellow Award, Hematology/Oncology Division, University of California, San Francisco Medical Center, San Francisco, CA
  • 2014
    American Society of Hematology (ASH) Research Training Award for Fellows, Senior Investigator Award

Selected Publications

  1. Gupta NK, Wang CC, Mannis GN, Yu JJ, Rubenstein JL. Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy. Leuk Lymphoma. 2017 Apr 10; 1-4.
    View on PubMed
  2. Eckhert EE, Schoenbeck KL, Galligan D, McNey LM, Hwang J, Mannis GN. Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant. Bone Marrow Transplant. 2017 Mar 13.
    View on PubMed
  3. Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol. 2016 Aug 30.
    View on PubMed
  4. Mulé MP, Mannis GN, Wood BL, Radich JP, Hwang J, Ramos NR, Andreadis C, Damon L, Logan AC, Martin TG, Hourigan CS. Multigene Measurable Residual Disease Assessment Improves AML Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 Aug 17.
    View on PubMed
  5. Mannis GN, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KM, Sayre PH, Wolf JL, Logan AC. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Jun; 22(6):1030-6.
    View on PubMed
  6. Mannis TE, Mannis GN, Waterhouse EG, Aldave AJ, Rose-Nussbaumer J. Paraproteinemic Keratopathy as the Presenting Sign of Hematologic Malignancy. Am J Hematol. 2016 Feb 12.
    View on PubMed
  7. Mannis GN, McNey LM, Gupta NK, Gross DM. The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care. Am J Hematol. 2016 Jun; 91(4):364-5.
    View on PubMed
  8. Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission. Leuk Lymphoma. 2016 Jul; 57(7):1560-6.
    View on PubMed
  9. Byrne M, Mannis GN, Nair J, Andreadis C. Inferior vena cava filter thrombosis. Clin Case Rep. 2016 Feb; 4(2):162-4.
    View on PubMed
  10. Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG. A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):377-83.
    View on PubMed
  11. Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, Venstrom JM, Wolf JL, Caballero L, Emi N, Martin TG. Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. Bone Marrow Transplant. 2015 Jan; 50(1):40-4.
    View on PubMed
  12. Mannis G, Wu D, Dea T, Mauro T, Hsu G. Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia. Am J Hematol. 2015 Feb; 90(2):179.
    View on PubMed
  13. Rubenstein JL, Gupta NK, Mannis GN, Lamarre AK, Treseler P. How I treat CNS lymphomas. Blood. 2013 Oct 3; 122(14):2318-30.
    View on PubMed
  14. Mannis GN, Fehniger JE, Creasman JS, Jacoby VL, Beattie MS. Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing. JAMA Intern Med. 2013 Jan 28; 173(2):96-103.
    View on PubMed

Go to UCSF Profiles, powered by CTSI